600267 海正药业
已收盘 07-19 15:00:00
资讯
新帖
简况
海正药业07月17日获主力加仓535万元 环比增加345.83%
自选股智能写手 · 07-17 15:17
海正药业07月17日获主力加仓535万元 环比增加345.83%
动物疫苗概念盘中拉升,科前生物涨3.91%
自选股智能写手 · 07-17 13:03
动物疫苗概念盘中拉升,科前生物涨3.91%
海正药业最新公告:拟向昂睿医药增资4800万元
证券之星 · 07-16
海正药业最新公告:拟向昂睿医药增资4800万元
超级真菌概念盘中跳水,海正药业跌1.25%
自选股智能写手 · 07-15
超级真菌概念盘中跳水,海正药业跌1.25%
北向资金7月12日净买入海正药业35.33万股 连续3日增持
自选股智能写手 · 07-15
北向资金7月12日净买入海正药业35.33万股 连续3日增持
海正药业最新公告:注射用替考拉宁通过仿制药一致性评价
证券之星 · 07-11
海正药业最新公告:注射用替考拉宁通过仿制药一致性评价
海正药业(600267.SH):注射用替考拉宁通过仿制药一致性评价
智通财经 · 07-11
海正药业(600267.SH):注射用替考拉宁通过仿制药一致性评价
海正药业(600267.SH)子公司米氮平软膏获批五类新兽药
智通财经 · 07-11
海正药业(600267.SH)子公司米氮平软膏获批五类新兽药
海正药业最新公告:子公司获得新兽药注册证书
证券之星 · 07-11
海正药业最新公告:子公司获得新兽药注册证书
海正药业最新公告:子公司依维莫司原料药获化学原料药上市申请批准通知书
证券之星 · 07-10
海正药业最新公告:子公司依维莫司原料药获化学原料药上市申请批准通知书
海正药业(600267.SH):依维莫司原料药获批上市
智通财经 · 07-10
海正药业(600267.SH):依维莫司原料药获批上市
海正药业07月10日遭主力抛售92万元 环比增加9100.00%
自选股智能写手 · 07-10
海正药业07月10日遭主力抛售92万元 环比增加9100.00%
超级真菌概念盘中跳水,海正药业跌1.12%
自选股智能写手 · 07-08
超级真菌概念盘中跳水,海正药业跌1.12%
青蒿素概念盘中拉升,海正药业涨3.62%
自选股智能写手 · 07-05
青蒿素概念盘中拉升,海正药业涨3.62%
动物疫苗概念盘中跳水,海正药业跌0.98%
自选股智能写手 · 07-04
动物疫苗概念盘中跳水,海正药业跌0.98%
海正药业(600267.SH)控股子公司海正动保公司获得新兽药注册证书
智通财经 · 07-01
海正药业(600267.SH)控股子公司海正动保公司获得新兽药注册证书
海正药业:获头孢泊肟酯咀嚼片新兽药注册证书
证券时报网 · 07-01
海正药业:获头孢泊肟酯咀嚼片新兽药注册证书
海正药业: 产品取得注册证
每日经济新闻 · 06-26
海正药业: 产品取得注册证
海正药业最新公告:子公司获得注射用阿糖胞苷药品注册证书
证券之星 · 06-26
海正药业最新公告:子公司获得注射用阿糖胞苷药品注册证书
海正药业:注射用阿糖胞苷获药品注册证书
证券时报网 · 06-26
海正药业:注射用阿糖胞苷获药品注册证书
加载更多
公司概况
公司名称:
浙江海正药业股份有限公司
所属行业:
医药制造业
上市日期:
2000-07-25
主营业务:
浙江海正药业股份有限公司主营化学原料药和制剂的研发、生产和销售业务,公司的主要产品及服务是医药制剂-自营业务、医药制剂-渠道及创新业务等。公司先后获得“国家高新技术企业”、“全国五一劳动奖状”等荣誉,入选国家首批“创新型企业”、“国家知识产权示范企业”。
发行价格:
11.83
{"stockData":{"symbol":"600267","market":"SH","secType":"STK","nameCN":"海正药业","latestPrice":7.34,"timestamp":1721372400000,"preClose":7.37,"halted":0,"volume":8353560,"delay":0,"floatShares":1192000000,"shares":1208000000,"eps":-0.0637,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.03,"latestTime":"07-19 15:00:00","open":7.34,"high":7.4,"low":7.3,"amount":61317600,"amplitude":0.0136,"askPrice":7.35,"askSize":719,"bidPrice":7.34,"bidSize":120,"shortable":0,"etf":0,"ttmEps":-0.0637,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":7.37,"symbolType":"stock","openAndCloseTimeList":[[1721352600000,1721359800000],[1721365200000,1721372400000]],"highLimit":8.11,"lowLimit":6.63,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1207873716,"pbRate":1.11,"roa":"--","roe":"3.1%","epsLYR":-0.08,"committee":-0.455757,"marketValue":8866000000,"floatMarketCap":8748000000,"peRate":-115.227633,"changeRate":-0.0041,"turnoverRate":0.007,"status":1},"requestUrl":"/m/hq/s/600267","defaultTab":"news","newsList":[{"id":"2452918632","title":"海正药业07月17日获主力加仓535万元 环比增加345.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452918632","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452918632?lang=zh_cn&edition=full","pubTime":"2024-07-17 15:17","pubTimestamp":1721200673,"startTime":"0","endTime":"0","summary":"07月17日, 海正药业股价涨1.84%,报收7.21元,成交金额6033万元,换手率0.71%,振幅2.54%,量比1.38。海正药业今日主力资金净流入535万元,连续3日净流入,上一交易日主力净流入120万元,今日环比增加345.83%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为28.57%,平均涨幅为1.17%。该股近5个交易日上涨3.89%,主力资金累计净流入268万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流出3068万元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171521269f5bc8ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171521269f5bc8ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600267","BK0239","BK0028","BK0188","BK0060"],"gpt_icon":0},{"id":"2452011219","title":"动物疫苗概念盘中拉升,科前生物涨3.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452011219","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452011219?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:03","pubTimestamp":1721192620,"startTime":"0","endTime":"0","summary":"07月17日,动物疫苗概念盘中拉升,截至13点03分,动物疫苗概念整体指数上涨1.09%,报671.590点。从个股上来看,该概念的成分股中,科前生物涨3.91%,康华生物、ST天邦、海正药业涨幅居前。从资金上来看,截止发稿,动物疫苗概念主力净流入为-3181.49万,其中海正药业受到资金热捧,主力净流入237.21万;拉长时间线来看,该板块近20日主力资金净流入-3.97亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717130340af92b2c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717130340af92b2c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","600267","688526","159646"],"gpt_icon":0},{"id":"2451969951","title":"海正药业最新公告:拟向昂睿医药增资4800万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451969951","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451969951?lang=zh_cn&edition=full","pubTime":"2024-07-16 17:49","pubTimestamp":1721123383,"startTime":"0","endTime":"0","summary":"海正药业公告,根据公司战略发展需求,为改善昂睿医药资产结构,降低其资产负债率,促进其日常运营及发展,提升公司创新药研发效能,同意公司以自有资金向昂睿医药增资4800万元,增加其注册资本4800万元。本次增资完成后,昂睿医药注册资本将增加至5000万元,公司仍持有其100%的股权。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600036139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","159938","BK0239","BK1574","BK0060","BK1515","BK0028","09939","BK0188","600267"],"gpt_icon":0},{"id":"2451466396","title":"超级真菌概念盘中跳水,海正药业跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451466396","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451466396?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:47","pubTimestamp":1721008068,"startTime":"0","endTime":"0","summary":"07月15日,超级真菌概念盘中跳水,截至09点47分,超级真菌概念整体指数下跌1.03%,报628.340点。从个股上来看,该概念的成分股中,海正药业跌1.25%,上海凯宝、重药控股、白云山跌幅居前。从资金上来看,截止发稿,超级真菌概念主力净流入为-1417.87万,其中国药现代受到资金热捧,主力净流入504.91万;拉长时间线来看,该板块近20日主力资金净流入-8.54亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715094748aef9a287&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715094748aef9a287&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600267","BK0060","BK0028","BK0239","BK0188"],"gpt_icon":0},{"id":"2451657805","title":"北向资金7月12日净买入海正药业35.33万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2451657805","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451657805?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:30","pubTimestamp":1721007010,"startTime":"0","endTime":"0","summary":"7月12日, 北向资金增持海正药业35.33万股,连续3日增持。截止当日收盘,沪股通共持有海正药业1133.83万股,占流通股0.95%。沪股通增持金额前五个股分别为招商银行、中远海控、澜起科技、中国平安、工商银行。海正药业近5个交易日上涨0.84%,沪股通累计增持14.22万股;近20个交易日下跌4.64%,沪股通累计减持1.81万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150930499f4ba34b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150930499f4ba34b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","600267","BK0188","BK0060"],"gpt_icon":0},{"id":"2450366041","title":"海正药业最新公告:注射用替考拉宁通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2450366041","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450366041?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:30","pubTimestamp":1720708246,"startTime":"0","endTime":"0","summary":"海正药业公告,近日,公司收到国家药品监督管理局核准签发的注射用替考拉宁药品补充申请批准通知书,公司药品注射用替考拉宁已通过仿制药质量和疗效一致性评价。注射用替考拉宁适用于治疗各种严重的革兰阳性菌感染。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100043070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0060","600267","BK0028"],"gpt_icon":0},{"id":"2450935339","title":"海正药业(600267.SH):注射用替考拉宁通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2450935339","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450935339?lang=zh_cn&edition=full","pubTime":"2024-07-11 17:33","pubTimestamp":1720690392,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海正药业 发布公告,近日,公司收到国家药品监督管理局核准签发的注射用替考拉宁《药品补充申请批准通知书》,公司药品注射用替考拉宁已通过仿制药质量和疗效一致性评价。注射用替考拉宁适用于治疗各种严重的革兰阳性菌感染,包括不能用青霉素类和头孢菌素类其他抗生素者;不能用青霉素类及头孢菌素类抗生素治疗或用上述抗生素治疗失败的严重葡萄球菌感染,或对其他抗生素耐药的葡萄球菌感染。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1149416.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600267","BK0060","BK0028","BK0239","BK0188"],"gpt_icon":0},{"id":"2450339939","title":"海正药业(600267.SH)子公司米氮平软膏获批五类新兽药","url":"https://stock-news.laohu8.com/highlight/detail?id=2450339939","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450339939?lang=zh_cn&edition=full","pubTime":"2024-07-11 17:31","pubTimestamp":1720690276,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海正药业(600267.SH)发布公告,近日,公司控股子公司浙江海正动物保健品有限公司(以下简称“海正动保公司”)收到中华人民共和国农业农村部核准签发的米氮平软膏《新兽药注册证书》,该新兽药产品正式获批五类新兽药。米氮平软膏是海正动保公司等5家公司共同研制的首家获批的五类新兽药。米氮平软膏适用于控制猫体重减轻。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1149413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","600267","BK0188","BK0060","BK0028"],"gpt_icon":0},{"id":"2450339403","title":"海正药业最新公告:子公司获得新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2450339403","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450339403?lang=zh_cn&edition=full","pubTime":"2024-07-11 17:31","pubTimestamp":1720690263,"startTime":"0","endTime":"0","summary":"海正药业公告,控股子公司海正动保公司收到农业农村部核准签发的米氮平软膏《新兽药注册证书》,该新兽药产品正式获批五类新兽药。米氮平软膏是海正动保公司等5家公司共同研制的首家获批的五类新兽药,适用于控制猫体重减轻。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100034658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0188","600267","BK0060"],"gpt_icon":0},{"id":"2450198811","title":"海正药业最新公告:子公司依维莫司原料药获化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2450198811","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450198811?lang=zh_cn&edition=full","pubTime":"2024-07-10 23:00","pubTimestamp":1720623612,"startTime":"0","endTime":"0","summary":"海正药业公告,近日,公司全资子公司海正杭州公司收到国家药品监督管理局核准签发的依维莫司原料药的《化学原料药上市申请批准通知书》。依维莫司适用于既往接受舒尼替尼或索拉非尼治疗失败的晚期肾细胞癌成人患者等。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000047820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600267","BK0028","BK0060"],"gpt_icon":0},{"id":"2450697018","title":"海正药业(600267.SH):依维莫司原料药获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2450697018","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450697018?lang=zh_cn&edition=full","pubTime":"2024-07-10 17:49","pubTimestamp":1720604966,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海正药业 公告,近日,公司全资子公司海正药业(杭州)有限公司收到国家药品监督管理局核准签发的依维莫司原料药的《化学原料药上市申请批准通知书》。依维莫司临床上还可用于预防肾移植和心脏移植手术后的排斥反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","600267","BK0188","BK0028","BK0239"],"gpt_icon":0},{"id":"2450515618","title":"海正药业07月10日遭主力抛售92万元 环比增加9100.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450515618","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450515618?lang=zh_cn&edition=full","pubTime":"2024-07-10 15:18","pubTimestamp":1720595899,"startTime":"0","endTime":"0","summary":"07月10日, 海正药业股价跌0.29%,报收6.94元,成交金额4039万元,换手率0.49%,振幅2.87%,量比0.68。海正药业今日主力资金净流出92万元,上一交易日主力净流出1万元,今日环比增加9100.00%。该股近5个交易日下跌2.94%,主力资金累计净流出1907万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出3573万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710152711959cd4dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710152711959cd4dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0028","BK0060","BK0188","600267"],"gpt_icon":0},{"id":"2449718385","title":"超级真菌概念盘中跳水,海正药业跌1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449718385","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449718385?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:36","pubTimestamp":1720402593,"startTime":"0","endTime":"0","summary":"07月08日,超级真菌概念盘中跳水,截至09点36分,超级真菌概念整体指数下跌2.06%,报633.370点。从个股上来看,该概念的成分股中,海正药业跌1.12%,国药现代、未名医药、重药控股跌幅居前。从资金上来看,截止发稿,超级真菌概念主力净流入为-4891.31万,其中华兰生物受到资金热捧,主力净流入193.37万;拉长时间线来看,该板块近20日主力资金净流入-5.88亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708093633941f494b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708093633941f494b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0060","BK0028","BK0239","600267"],"gpt_icon":0},{"id":"2449623684","title":"青蒿素概念盘中拉升,海正药业涨3.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449623684","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449623684?lang=zh_cn&edition=full","pubTime":"2024-07-05 14:06","pubTimestamp":1720159574,"startTime":"0","endTime":"0","summary":"07月05日,青蒿素概念盘中拉升,截至14点06分,青蒿素概念整体指数上涨2.01%,报1062.250点。从个股上来看,该概念的成分股中,海正药业涨3.62%,润都股份、复星医药、华润双鹤涨幅居前。从资金上来看,截止发稿,青蒿素概念主力净流入为-6827.17万,其中华润双鹤受到资金热捧,主力净流入393.04万;拉长时间线来看,该板块近20日主力资金净流入2790.59万。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705140614aef81566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705140614aef81566&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","600267","BK0239","600062","BK0060","BK0188"],"gpt_icon":0},{"id":"2448466124","title":"动物疫苗概念盘中跳水,海正药业跌0.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448466124","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448466124?lang=zh_cn&edition=full","pubTime":"2024-07-04 09:46","pubTimestamp":1720057592,"startTime":"0","endTime":"0","summary":"07月04日,动物疫苗概念盘中跳水,截至09点46分,动物疫苗概念整体指数下跌0.54%,报665.940点。从个股上来看,该概念的成分股中,海正药业跌0.98%,瑞普生物、天康生物、中牧股份跌幅居前。从资金上来看,截止发稿,动物疫苗概念主力净流入为-497.78万,其中温氏股份受到资金热捧,主力净流入418.65万;拉长时间线来看,该板块近20日主力资金净流入-5.20亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704094632941f3ab4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704094632941f3ab4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159646","BK0188","600267","BK0060","BK0239","BK0028"],"gpt_icon":0},{"id":"2448799988","title":"海正药业(600267.SH)控股子公司海正动保公司获得新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2448799988","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448799988?lang=zh_cn&edition=full","pubTime":"2024-07-01 19:41","pubTimestamp":1719834076,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海正药业(600267.SH)公告,公司控股子公司浙江海正动物保健品有限公司(简称“海正动保公司”)收到中华人民共和国农业农村部核准签发的头孢泊肟酯咀嚼片《新兽药注册证书》,该新兽药产品正式获批五类新兽药。据悉,头孢泊肟酯咀嚼片适用于治疗由假中间葡萄球菌、金黄色葡萄球菌、犬链球菌(G组,β溶血)、大肠杆菌、多杀性巴氏杆菌、奇异变形杆菌等易感菌引起的犬皮肤感染(创伤和脓肿)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1143793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0188","BK0060","600267","BK0028"],"gpt_icon":0},{"id":"2448334996","title":"海正药业:获头孢泊肟酯咀嚼片新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2448334996","media":"证券时报网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448334996?lang=zh_cn&edition=full","pubTime":"2024-07-01 19:13","pubTimestamp":1719832380,"startTime":"0","endTime":"0","summary":"证券时报e公司讯,海正药业(600267)7月1日晚间公告,近日公司控股子公司海正动保公司收到农业农村部核准签发的头孢泊肟酯咀嚼片新兽药注册证书,该新兽药产品正式获批五类新兽药。头孢泊肟酯咀嚼片适用于治疗由假中间葡萄球菌、金黄色葡萄球菌、犬链球菌(G组,β溶血)、大肠杆菌、多杀性巴氏杆菌、奇异变形杆菌等易感菌引起的犬皮肤感染(创伤和脓肿)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701191414955ea4a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701191414955ea4a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0188","BK0060","600267","BK0028"],"gpt_icon":0},{"id":"2446350679","title":"海正药业: 产品取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2446350679","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446350679?lang=zh_cn&edition=full","pubTime":"2024-06-26 18:03","pubTimestamp":1719396227,"startTime":"0","endTime":"0","summary":"每经AI快讯,海正药业 6月26日晚间发布公告称,浙江海正药业股份有限公司全资子公司瀚晖制药有限公司于近日收到国家药品监督管理局核准签发的注射用阿糖胞苷《药品注册证书》。产品名称为“注射用阿糖胞苷”。2023年1至12月份,海正药业的营业收入构成为:医药生产占比54.78%,药品销售占比42.82%,CMO/CDMO/CRO业务占比0.25%,其他行业占比0.08%。截至发稿,海正药业市值为87亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062618041095d9e05b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062618041095d9e05b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600267","BK0188","BK0239","BK0060","BK0028"],"gpt_icon":0},{"id":"2446835022","title":"海正药业最新公告:子公司获得注射用阿糖胞苷药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2446835022","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446835022?lang=zh_cn&edition=full","pubTime":"2024-06-26 18:00","pubTimestamp":1719396031,"startTime":"0","endTime":"0","summary":"海正药业公告,全资子公司瀚晖制药有限公司于近日收到国家药品监督管理局核准签发的注射用阿糖胞苷《药品注册证书》。注射用阿糖胞苷主要适用于成人和儿童急性非淋巴细胞性白血病的诱导缓解和维持治疗。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062600036462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0060","600267","BK0239"],"gpt_icon":0},{"id":"2446635067","title":"海正药业:注射用阿糖胞苷获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2446635067","media":"证券时报网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446635067?lang=zh_cn&edition=full","pubTime":"2024-06-26 17:56","pubTimestamp":1719395760,"startTime":"0","endTime":"0","summary":"证券时报e公司讯,海正药业(600267)6月26日晚间公告,全资子公司瀚晖制药注射用盐酸伊达比星收到《药品补充申请批准通知书》,注射用阿糖胞苷收到《药品注册证书》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062617571595d9dba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062617571595d9dba8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600267","BK0060","BK0239","BK0028","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2000-07-25","address":"浙江省台州市椒江区外沙路46号","stockEarnings":[{"period":"1week","weight":0.025},{"period":"1month","weight":-0.0173},{"period":"3month","weight":-0.0041},{"period":"6month","weight":-0.1672},{"period":"1year","weight":-0.3288},{"period":"ytd","weight":-0.2126}],"companyName":"浙江海正药业股份有限公司","boardCode":"AI0027","perCapita":"19406股","boardName":"医药制造业","registeredCapital":"120787万元","compareEarnings":[{"period":"1week","weight":0.0023},{"period":"1month","weight":-0.0175},{"period":"3month","weight":-0.0288},{"period":"6month","weight":0.0511},{"period":"1year","weight":-0.0693},{"period":"ytd","weight":0.0007}],"survey":" 浙江海正药业股份有限公司主营化学原料药和制剂的研发、生产和销售业务,公司的主要产品及服务是医药制剂-自营业务、医药制剂-渠道及创新业务等。公司先后获得“国家高新技术企业”、“全国五一劳动奖状”等荣誉,入选国家首批“创新型企业”、“国家知识产权示范企业”。","serverTime":1721391995881,"listedPrice":11.83,"stockholders":"61413人(较上一季度减少2.94%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海正药业(600267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海正药业(600267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海正药业,600267,海正药业股票,海正药业股票老虎,海正药业股票老虎国际,海正药业行情,海正药业股票行情,海正药业股价,海正药业股市,海正药业股票价格,海正药业股票交易,海正药业股票购买,海正药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海正药业(600267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海正药业(600267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}